CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis
USA - NASDAQ:CREX - US22530J3095 - Common Stock
2.31 USD
+0.04 (+1.99%)
2.3899 USD
+0.08 (+3.46%)
Taking everything into account, CREX scores 3 out of 10 in our fundamental rating. CREX was compared to 99 industry peers in the Media industry. CREX has a bad profitability rating. Also its financial health evaluation is rather negative. CREX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CREX was profitable.
In the past year CREX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CREX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CREX reported negative operating cash flow in multiple years.
1.2 Ratios
CREX has a Return On Assets (-0.05%) which is in line with its industry peers.
The Return On Equity of CREX (-0.10%) is comparable to the rest of the industry.
The Return On Invested Capital of CREX (0.43%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.05% | ||
| ROE | -0.1% | ||
| ROIC | 0.43% |
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Operating Margin of CREX (0.60%) is worse than 61.62% of its industry peers.
CREX has a Gross Margin (46.99%) which is comparable to the rest of the industry.
CREX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.6% | ||
| PM (TTM) | N/A | ||
| GM | 47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
2. Health
2.1 Basic Checks
CREX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
Compared to 5 years ago, CREX has more shares outstanding
Compared to 1 year ago, CREX has a worse debt to assets ratio.
2.2 Solvency
CREX has an Altman-Z score of 0.06. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.06, CREX is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.78 indicates that CREX is somewhat dependend on debt financing.
The Debt to Equity ratio of CREX (0.78) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.06 |
ROIC/WACC0.06
WACC6.93%
2.3 Liquidity
CREX has a Current Ratio of 1.23. This is a normal value and indicates that CREX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CREX (1.23) is comparable to the rest of the industry.
A Quick Ratio of 1.10 indicates that CREX should not have too much problems paying its short term obligations.
CREX has a Quick ratio (1.10) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 488.89% over the past year.
CREX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.59%.
CREX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.98% yearly.
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%
3.2 Future
Based on estimates for the next years, CREX will show a very strong growth in Earnings Per Share. The EPS will grow by 53.47% on average per year.
Based on estimates for the next years, CREX will show a quite strong growth in Revenue. The Revenue will grow by 11.12% on average per year.
EPS Next Y144.82%
EPS Next 2Y53.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.11%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CREX is valuated cheaply with a Price/Earnings ratio of 6.60.
Compared to the rest of the industry, the Price/Earnings ratio of CREX indicates a rather cheap valuation: CREX is cheaper than 89.90% of the companies listed in the same industry.
CREX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.27.
CREX is valuated rather expensively with a Price/Forward Earnings ratio of 19.69.
Based on the Price/Forward Earnings ratio, CREX is valued a bit cheaper than the industry average as 61.62% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CREX to the average of the S&P500 Index (22.77), we can say CREX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.6 | ||
| Fwd PE | 19.69 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CREX is valued a bit cheaper than the industry average as 61.62% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.65 |
4.3 Compensation for Growth
CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CREX's earnings are expected to grow with 53.47% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y53.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CREX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.31
+0.04 (+1.99%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners15.67%
Inst Owner Change24.5%
Ins Owners17.62%
Ins Owner Change25.71%
Market Cap24.30M
Analysts84
Price Target6.76 (192.64%)
Short Float %2.52%
Short Ratio2.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)230.68%
Min EPS beat(2)-140.1%
Max EPS beat(2)601.45%
EPS beat(4)3
Avg EPS beat(4)160.43%
Min EPS beat(4)-140.1%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)4.23%
Revenue beat(4)3
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)4.23%
Revenue beat(8)3
Avg Revenue beat(8)-4.2%
Revenue beat(12)3
Avg Revenue beat(12)-4.26%
Revenue beat(16)3
Avg Revenue beat(16)-3.68%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.04%
EPS NY rev (1m)-65.06%
EPS NY rev (3m)166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-4.74%
Revenue NY rev (3m)-4.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.6 | ||
| Fwd PE | 19.69 | ||
| P/S | 0.5 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.81 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.65 |
EPS(TTM)0.35
EY15.15%
EPS(NY)0.12
Fwd EY5.08%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.59
BVpS2.84
TBVpS-1.8
PEG (NY)0.05
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.05% | ||
| ROE | -0.1% | ||
| ROCE | 0.55% | ||
| ROIC | 0.43% | ||
| ROICexc | 0.44% | ||
| ROICexgc | 6.2% | ||
| OM | 0.6% | ||
| PM (TTM) | N/A | ||
| GM | 47% | ||
| FCFM | N/A |
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.72
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 58.56% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 0.26 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 0.06 |
F-Score3
WACC6.93%
ROIC/WACC0.06
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
EPS Next Y144.82%
EPS Next 2Y53.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%
Revenue Next Year4.11%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year709.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.33%
OCF growth 3Y93.04%
OCF growth 5YN/A